Amicus Therapeutics Inc.

NASDAQ: FOLD · Real-Time Price · USD
7.42
0.02 (0.27%)
At close: Aug 18, 2025, 3:59 PM
7.41
-0.13%
After-hours: Aug 18, 2025, 04:41 PM EDT

Amicus Therapeutics Revenue

Amicus Therapeutics reported an annual revenue of $528.29M, reflecting a 32.29% growth. For the quarter ending June 30, 2025, Amicus Therapeutics generated $154.69M in revenue.
Revenue (ttm)
528.29M
Revenue Growth
32.29%
Price / Sales Ratio
5.43
Revenue / Employee
1.06M
Employees
499
Market Cap
2.29B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 528.29M +32.29%
Dec 31, 2023 399.36M +21.30%
Dec 31, 2022 329.23M +7.76%
Dec 31, 2021 305.51M +17.11%
Dec 31, 2020 260.89M +43.16%
Dec 31, 2019 182.24M +99.72%
Dec 31, 2018 91.25M +147.08%
Dec 31, 2017 36.93M +644.86%
Dec 31, 2016 4.96M +Infinity%
Dec 31, 2015 0 -100.00%
Dec 31, 2014 1.22M +237.19%
Dec 31, 2013 363K -98.03%
Dec 31, 2012 18.41M -14.10%
Dec 31, 2011 21.43M +2224.73%
Dec 31, 2010 922K -98.57%
Dec 31, 2009 64.36M +330.00%
Dec 31, 2008 14.97M +738.96%
Dec 31, 2007 1.78M +Infinity%
Dec 31, 2006 0 n/a
Dec 31, 2005 0 n/a
Dec 31, 2004 0 n/a
Dec 31, 2003 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.